Fluorine-18 DOPA PET imaging of paraganglioma syndrome

Clin Nucl Med. 2006 Jan;31(1):39-41. doi: 10.1097/01.rlu.0000191577.39458.a0.

Abstract

A 12-year-old boy was admitted after recently having had a resection performed of an extraadrenal retroperitoneal paraganglioma and left adrenalectomy for pheochromocytoma. Despite these procedures, the blood pressure and urinary noradrenalin were elevated. Screening with fluorine-18 DOPA PET demonstrated increased tracer uptake in the right adrenal gland, in a second abdominal lesion, which was prevertebral, and 2 cervical hot spots near the carotid bifurcation, one on each side of the neck. The patient carries a mutation of the gene Succinate dehydrogenasis subunits D (SDHD) and is thus classified with the paraganglioma syndrome type 1.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Neoplasms / diagnostic imaging*
  • Abdominal Neoplasms / genetics
  • Child
  • Dihydroxyphenylalanine / analogs & derivatives*
  • Head and Neck Neoplasms / diagnostic imaging*
  • Head and Neck Neoplasms / genetics
  • Humans
  • Male
  • Paraganglioma / diagnostic imaging*
  • Paraganglioma / genetics
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals
  • Succinate Dehydrogenase / genetics
  • Syndrome

Substances

  • Radiopharmaceuticals
  • fluorodopa F 18
  • Dihydroxyphenylalanine
  • Succinate Dehydrogenase